A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis
By
Adam G. Laing,
Anna Lorenc,
Irene del Molino del Barrio,
Abhishek Das,
Matthew Fish,
Leticia Monin-Aldama,
Miguel Munoz-Ruiz,
Duncan R. McKenzie,
Thomas S. Hayday,
Isaac Francos Quijorna,
Shraddha Kamdar,
Magdalene Joseph,
Daniel Davies,
Richard Davis,
Aislinn Jennings,
Iva Zlatareva,
Pierre Vantourout,
Yin Wu,
Vasiliki Sofra,
Florencia Cano,
Maria Greco,
Efstathios Theodoridis,
Joshua Freedman,
Sarah Gee,
Julie Nuo En, Chan,
Sarah Ryan,
Eva Bugallo Blanco,
Part Peterson,
Kai Kisand,
Liis Haljasmagi,
Lauren Martinez,
Blair Merrick,
Karen Bisnauthsing,
Kate Brooks,
Mohammad Ibrahim,
Jeremy Mason,
Federico Lopez Gomez,
Kola Babalola,
Sultan Abdul- Jawad,
John Cason,
Christine Mant,
Katie J Doores,
Jeffrey Seow,
Carl Graham,
Francesca Di Rosa,
Jonathan D. Edgeworth,
Manu Shankar-Hari,
Adrian Adrian C. Hayday
Posted 09 Jun 2020
medRxiv DOI: 10.1101/2020.06.08.20125112
Person-to-person transmission of SARS-CoV-2 virus has triggered a global emergency because of its potential to cause life-threatening Covid-19 disease. By comparison to pauci-symptomatic virus clearance by most individuals, Covid-19 has been proposed to reflect insufficient and/or pathologically exaggerated immune responses. Here we identify a consensus peripheral blood immune signature across 63 hospital-treated Covid-19 patients who were otherwise highly heterogeneous. The core signature conspicuously blended adaptive B cell responses typical of virus infection or vaccination with discrete traits hitherto associated with sepsis, including monocyte and dendritic cell dampening, and hyperactivation and depletion of discrete T cell subsets. This blending of immuno-protective and immuno-pathogenic potentials was exemplified by near-universal CXCL10/IP10 upregulation, as occurred in SARS1 and MERS. Moreover, specific parameters including CXCL10/IP10 over-expression, T cell proliferation, and basophil and plasmacytoid dendritic cell depletion correlated, often prognostically, with Covid-19 progression, collectively composing a resource to inform SARS-CoV-2 pathobiology and risk-based patient stratification.
Download data
- Downloaded 5,647 times
- Download rankings, all-time:
- Site-wide: 2,615
- In infectious diseases: 674
- Year to date:
- Site-wide: 35,001
- Since beginning of last month:
- Site-wide: 42,929
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!